JAUNDICE DURING TREATMENT WITH AN ORAL CONTRACEPTIVE, LYNDIOL

Cullberg G, G Cullberg, LUNDSTROEM R, R LUNDSTROEM, STENRAM U, U STENRAM
British medical journal · 1965 · vol. 1(5436) , pp. 695–7 · doi:10.1136/bmj.1.5436.695 · PMID:14245208 · PMC2166417
Other OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-25 ⓘ

This case report describes the development of jaundice in a patient receiving treatment with the oral contraceptive Lyndiol.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Alanine Transaminase Alkaline Phosphatase Aspartate Aminotransferases Bilirubin Biopsy Chemical and Drug Induced Liver Injury Contraceptives, Oral D-Alanine Transaminase Hepatitis Jaundice Liver Function Tests Lynestrenol Mestranol Pathology Toxicology Alkaline Phosphatase Drug Combinations Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-01T09:25:17.647243+00:00
pubmed
last seen: 2026-10-08T21:01:56.755204+00:00
unpaywall
last seen: 2026-11-06T06:34:47.334260+00:00